Compare OCS & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OCS | VMD |
|---|---|---|
| Founded | 2003 | 2006 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.3M | 351.6M |
| IPO Year | 2022 | 2018 |
| Metric | OCS | VMD |
|---|---|---|
| Price | $7.50 | $8.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 2 |
| Target Price | ★ $35.89 | $12.00 |
| AVG Volume (30 Days) | ★ 253.1K | 176.9K |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.14 |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $270,280,000.00 |
| Revenue This Year | N/A | $17.63 |
| Revenue Next Year | $389.20 | $11.23 |
| P/E Ratio | ★ N/A | $37.33 |
| Revenue Growth | N/A | ★ 20.52 |
| 52 Week Low | $6.78 | $6.31 |
| 52 Week High | $34.48 | $12.61 |
| Indicator | OCS | VMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.30 | 36.19 |
| Support Level | $6.95 | $8.57 |
| Resistance Level | $8.84 | $10.07 |
| Average True Range (ATR) | 0.65 | 0.35 |
| MACD | 0.06 | -0.08 |
| Stochastic Oscillator | 33.83 | 5.07 |
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.